Schering-Plough Articles
S-P's boceprevir boosts HCV clearance rates
29 October 2007
Stock Commentary - New York week to October 22, 2007
29 October 2007
Merck & Co's 3rd-qtr 2007 sales jump 12%
29 October 2007
Positive Ph II safety data on S-P's TRA
29 October 2007
S-P's 3rd-qtr 2007 net income surges 149%
29 October 2007
EC clears S-P's Organon acquistion
22 October 2007
Review of the annual meeting of the ECNP
22 October 2007
Europe leads surge in Pharma M&A deal values
1 October 2007
CHMP recommends S-P's HCV drug regimen
1 October 2007
Pharmacopeia to receive $1M milestone from S-P
27 September 2007
S-P begins two Ph III vicriviroc trials
24 September 2007
UK's NICE says Ezetrol is cost-effective
24 September 2007
Schering-Plough prices senior notes
17 September 2007
Xceleron to conduct microdosing study for Organon
17 September 2007
European cardiologists welcome lower cholesterol targets
10 September 2007
Santarus gets $5M milestone form S-P
3 September 2007
Drug Royalty buys 25% of Peg-Intron royalties
3 September 2007
PeriCor and S-P activate acadesine deal
3 September 2007
Stock Commentary - Europe - week to Aug 13, 2007
20 August 2007
Organon's muscle relaxant approved in Japan
6 August 2007
Schering-Plough to sue Barr on generic Temodar
30 July 2007
Organon and MRC sign cancer Ab development accord
30 July 2007
S-P licenses ARA drug from PeriCor
30 July 2007
S-P's 2nd-quarter 2007 EPS doubles to $0.34
30 July 2007
Merck & Co's 2nd-qtr 2007 EPS jumps 12%
30 July 2007
Stock Commentary - New York - week to July 16, 2007
23 July 2007
Organon and Dyax in therapeutic antibody accord
23 July 2007
J&J's 2nd-qtr 2007 net income jumps 9.2%
23 July 2007
Novacea gets $60M payment for S-P under Asentar deal
16 July 2007
ICI tells Akzo to "put-up-or-shut-up"
16 July 2007
Headlines 25 years ago this week....
18 June 2007
Toray seeks approval of Feron plus ribavirin
18 June 2007
S-P/Bayer's Zetia launched in Japan
18 June 2007
Remicade gets EC OK for pediatric CD
18 June 2007
Japan's Chuikyo adds 13 NCEs to NHI list
18 June 2007
S-P's Caelyx increases TTP in breast cancer
11 June 2007
Medarex and Organon enter Ab drug accord
21 May 2007
SMC approves S-P's Remicade in psoriasis
21 May 2007
Stock Commentary - New York week to May 7, 2007
14 May 2007
Phytopharm's loss narrows 22.2%
7 May 2007
EC clears S-P's desloratidine brands
7 May 2007
Stock Commentary - Europe - week to April 23, 2007
30 April 2007
Stock Commentary - New York week to April 23, 2007
30 April 2007
Schering-Plough 1st-qtr profits leap 55%
30 April 2007
S-P's oral antiplatelet drug to enter Ph III trials
30 April 2007
Merck & Co's 1st-qtr income climbs 12%
30 April 2007
Bayer/S-P's Zetia approved in Japan
23 April 2007
Stock Commentary - New York week to April 16, 2007
23 April 2007
J&J's 1st-qtr profits slip 22% on Conor buy
23 April 2007
S-P selects another Pharmacopeia drug
23 April 2007
Ranbaxy gets US approval for generic loratadine
16 April 2007
S-P
16 April 2007
S-P's Pegintron cleared in China for HBV
16 April 2007
Aveo and Schering-Plough in R&D accord
16 April 2007
Pharmacopeia gets $1M as S-P drug enters Ph I
9 April 2007
Merck & Co/S-P enter new LDL drug accord
2 April 2007
Stock Commentary - New York week to March 26
2 April 2007
S-P's TRA drug meets Ph II endpoints
2 April 2007
Remicade gets EMEA nod for new indication
2 April 2007
Stock Commentary - Europe - week to Mar 19
26 March 2007
NCCN advocates Noxafil for IFI in cancer patients
26 March 2007
Stock Commentary - Europe - week to March 12, 2007
26 March 2007
Stock Commentary - New York week to Mar 12, 2007
26 March 2007
S-P's Suboxone approved in Scotland
19 March 2007
Headlines 25 years ago this week....
19 March 2007
13 new drugs added to Japan's NHI list
19 March 2007
Ismail Kola named senior VP discovery at S-P
12 March 2007
EC clears new Remicade dosing for use in RA
12 March 2007
S-P looking for links in China and Japan
12 March 2007
MNCs in Serbia move for "transparency"
12 March 2007
Strong Ph II data for Schering-Plough's Caelyx
5 March 2007
S-P "actively" looking for acquisitions, says CEO Hassan
26 February 2007
PS522501 enters Ph I metabolic disease trial
26 February 2007
S-P's Caelyx impresses in Ph II cancer trial
26 February 2007
Now IFPMA promotes ethics on-line
26 February 2007
Analysts predict surge in Danish biotechs
19 February 2007
Shaju Backer named general manager of Aus/NZ division of S-P
12 February 2007
Remicade of benefit in treatment of psoriasis
12 February 2007
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
